Adar1 Capital Management, LLC Pro Qr Therapeutics N.V. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 20,394 shares of PRQR stock, worth $34,261. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,394
Previous 20,394
-0.0%
Holding current value
$34,261
Previous $54 Million
49.81%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
67Shares Held
40MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.6 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.38 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.52 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.48 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.45 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $120M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...